WHO ICTRP trial
Evaluation the effect of co-enzyme Q10 in patients with thalassemia major
IRCT20221211056777N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20221211056777N1 |
|---|---|
| Public title | Evaluation the effect of co-enzyme Q10 in patients with thalassemia major |
| Scientific title | Evaluation the effect of co-enzyme Q10 supplementation on inhibition of ferroptosis in patients with thalassemia major referred to Shahrekord Hajer Hospital |
| Primary sponsor | Shahre-kord University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 1 |
| Countries | Iran (Islamic Republic of) |
| Conditions | thalassemia major. Beta thalassemia;D56.1 |
| Interventions | 50 patients with thalassemia major are selected. The laboratory parameters (superoxide dismutase (SOD), catalase and glutathione peroxidase, ferritin, hemoglobin, ESR and CRP) will be checked by ELISA method for these patients before start… |
| Registration date | Jan 22, 2023 |
| Target size | 50 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: